Related Experiment Video

Updated: May 21, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Cardiovascular risk in patients submitted to liver transplantation

Hélem de Sena Ribeiro1, Lucilene Rezende Anastácio, Lívia Garcia Ferreira

  • 1Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. 　helemsena@gmail.com

Revista Da Associacao Medica Brasileira (1992)
|June 28, 2012
PubMed

Insights

Nearly half of liver transplant patients face medium to high cardiovascular risk, linked to male gender, older age, higher BMI, and cyclosporine use. This highlights the need for focused cardiovascular risk management in this population.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Liver transplantation is a life-saving procedure, but recipients face unique health challenges.
  • Cardiovascular disease (CVD) is a significant cause of morbidity and mortality post-transplant.
  • Assessing cardiovascular risk is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To determine the prevalence of cardiovascular risk in liver transplant recipients using the Framingham score.
  • To identify traditional and non-traditional risk factors associated with elevated cardiovascular risk in this cohort.
  • To compare cardiovascular risk in liver transplant patients to the general Brazilian population.

Main Methods:

  • A cross-sectional study involving 115 patients undergoing liver transplantation.
  • Patients were stratified by cardiovascular risk using the Framingham score.
  • Demographic, socioeconomic, clinical, and anthropometric data were collected and analyzed using univariate and multivariate statistics.

Main Results:

  • 46.1% of patients exhibited medium or high 10-year cardiovascular event risk.
  • Mean cardiovascular risk was 9.5 ± 7.8%.
  • Factors associated with increased risk included male gender (OR: 4.97), older age (OR: 1.09), higher BMI (OR: 1.09), and cyclosporine use (p=0.01).

Conclusions:

  • Liver transplant recipients have a higher probability of cardiovascular events than the general Brazilian population.
  • Particular attention is warranted for modifiable risk factors such as elevated BMI and cyclosporine use.
  • Proactive cardiovascular risk assessment and management are essential for this vulnerable patient group.
Abstract

More Related Videos

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...